Brief: Schott Pharma Christian Mias To Succeed Andreas Reisse As CEO
Nov 5 (Reuters) - SCHOTT PHARMA AG & CO KGAA 1SXP.DE: CHRISTIAN MIAS TO SUCCEED ANDREAS REISSE AS CEO HE WILL SUCCEED ANDREAS REISSE, WHO WILL RETIRE AS PLANNED AT END OF APRIL 2026 CHRISTIAN MIAS APPOINTED AS CEO EFFECTIVE MAY 1, 2026 Source text: ID:nEQ9yNdv5a Further company coverage: 1SXP.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SCHOTT Pharma AG & Co. KGaA
See all newsEurope Research Roundup: GSK, Schott Pharma, Vodafone
SCHOTT Pharma rises after J.P. Morgan initiates with 'Overweight'
Schott Pharma rises after Barclays upgrades to 'overweight' on accelerating growth outlook
Europe Research Roundup: Adyen, GYM Group, Rolls Royce
Brief: Schott Pharma - Confirms Recently Increased 2026 Financial Year Guidance